Trials / Completed
CompletedNCT01217125
Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis
CLINICAL TRIAL TO DETERMINE THE EFFICACY AND SAFETY OF RAPAMYCIN IN ANGIOMYOLIPOMAS IN PATIENTS WITH TUBEROUS SCLEROSIS
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Fundacio Puigvert · Academic / Other
- Sex
- All
- Age
- 10 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether rapamycin is safe and effective in the treatment of renal angiomyolipomas in patients with tuberousclerosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sirolimus | plasma levels between 4 and 8 |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2010-10-08
- Last updated
- 2012-03-08
Source: ClinicalTrials.gov record NCT01217125. Inclusion in this directory is not an endorsement.